Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Coherus Oncology, Inc. (CHRS)

0.8301 -0.0683 (-7.60%)
At close: October 30 at 4:00:01 PM EDT
0.8609 +0.0308 (+3.71%)
Pre-Market: 7:31:49 AM EST
Trade CHRS on Coinbase

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
128.25M 215.95M 260.56M 171.64M 190.61M 84.78M
Enterprise Value
62.60M 88.90M 128.78M 20.67M -6.00M 272.30M
Trailing P/E
-- -- -- -- -- --
Forward P/E
-- -- -- -- -- --
PEG Ratio (current)
-- -- -- -- -- --
Price/Sales
2.15 -- -- -- -- --
Price/Book
2.11 -- -- -- -- --
Enterprise Value/Revenue
1.23 1.90 3.05 0.25 0.01 1.38
Enterprise Value/EBITDA
-- -- -- -- -- --
6/30/2025 - 11/6/2014

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2025
Most Recent Quarter (mrq) 6/30/2026

Profitability

Profit Margin -259.41%
Operating Margin (ttm) -225.98%

Management Effectiveness

Return on Assets (ttm) -30.52%
Return on Equity (ttm) -178.39%

Income Statement

Revenue (ttm) 50.94M
Revenue Per Share (ttm) 0.39
Quarterly Revenue Growth (yoy) 39.50%
Gross Profit (ttm) 35.12M
EBITDA -150.39M
Net Income Avi to Common (ttm) -161.15M
Diluted EPS (ttm) -1.2500
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 105.31M
Total Cash Per Share (mrq) 0.68
Total Debt (mrq) 54.18M
Total Debt/Equity (mrq) 89.05%
Current Ratio (mrq) 1.77
Book Value Per Share (mrq) 0.39

Cash Flow Statement

Operating Cash Flow (ttm) -186.03M
Levered Free Cash Flow (ttm) -160.15M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52 Week Change 3 -48.12%
S&P 500 52-Week Change 3 10.63%
52 Week High 3 2.6160
52 Week Low 3 0.8050
50-Day Moving Average 3 1.1983
200-Day Moving Average 3 1.5306

Share Statistics

Avg Vol (3 month) 3 1.42M
Avg Vol (10 day) 3 1.63M
Shares Outstanding 5 154.5M
Implied Shares Outstanding 6 154.5M
Float 8 135.6M
% Held by Insiders 1 19.12%
% Held by Institutions 1 37.23%
Shares Short (10/15/2026) 4 12.45M
Short Ratio (10/15/2026) 4 7.31
Short % of Float (10/15/2026) 4 8.30%
Short % of Shares Outstanding (10/15/2026) 4 8.06%
Shares Short (prior month 9/15/2026) 4 22.85M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 0.00%
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: